GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 90 filers reported holding GW PHARMACEUTICALS PLC in Q3 2014. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $101,757,000 | -43.8% | 884,842 | -16.0% | 0.30% | -46.0% |
| Q2 2019 | $181,171,000 | -2.9% | 1,053,321 | -4.8% | 0.55% | -17.6% |
| Q1 2019 | $186,553,000 | +44.8% | 1,106,678 | -16.4% | 0.67% | +29.5% |
| Q4 2018 | $128,857,000 | -44.5% | 1,323,098 | -1.5% | 0.52% | -30.7% |
| Q3 2018 | $232,024,000 | +17.9% | 1,343,198 | -4.7% | 0.75% | +21.6% |
| Q2 2018 | $196,751,000 | +5.7% | 1,410,000 | -14.6% | 0.62% | +6.0% |
| Q1 2018 | $186,064,000 | -18.7% | 1,651,411 | -4.7% | 0.58% | -16.6% |
| Q4 2017 | $228,818,000 | +12.9% | 1,733,337 | -13.2% | 0.70% | +8.9% |
| Q3 2017 | $202,750,000 | +2.9% | 1,997,734 | +1.7% | 0.64% | -0.8% |
| Q2 2017 | $196,981,000 | -18.4% | 1,964,897 | -1.6% | 0.64% | -20.4% |
| Q1 2017 | $241,514,000 | +5.4% | 1,996,973 | -2.6% | 0.81% | +0.5% |
| Q4 2016 | $229,111,000 | +48.0% | 2,050,212 | +75.8% | 0.81% | +38.0% |
| Q3 2016 | $154,777,000 | +36.7% | 1,166,106 | -5.7% | 0.58% | +31.5% |
| Q2 2016 | $113,235,000 | +26.9% | 1,236,600 | 0.0% | 0.44% | +22.7% |
| Q1 2016 | $89,221,000 | +9.7% | 1,236,600 | +5.5% | 0.36% | +9.4% |
| Q4 2015 | $81,356,000 | -21.3% | 1,171,600 | +3.5% | 0.33% | -25.1% |
| Q3 2015 | $103,394,000 | -27.2% | 1,131,600 | -2.2% | 0.44% | -18.5% |
| Q2 2015 | $142,077,000 | +194.2% | 1,156,600 | +118.2% | 0.54% | +154.5% |
| Q1 2015 | $48,299,000 | -13.3% | 530,000 | -35.6% | 0.21% | -9.7% |
| Q4 2014 | $55,728,000 | -17.6% | 823,408 | -1.5% | 0.24% | -15.7% |
| Q3 2014 | $67,601,000 | -27.7% | 836,124 | -4.0% | 0.28% | -28.2% |
| Q2 2014 | $93,439,000 | +80.7% | 870,905 | 0.0% | 0.39% | +69.6% |
| Q1 2014 | $51,706,000 | +102.4% | 870,905 | +41.6% | 0.23% | +111.0% |
| Q4 2013 | $25,547,000 | +19.8% | 615,000 | -50.0% | 0.11% | +94.6% |
| Q3 2013 | $21,328,000 | +299.6% | 1,230,000 | +100.0% | 0.06% | +93.1% |
| Q2 2013 | $5,338,000 | – | 615,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|